We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Moderna发布了针对胰腺癌的个性化mRNA疫苗：78%的患者在18个月内缓解。FDA加速批准。疗效与风险分析。
